Skip to main content
Tech.euFundingExplorerBeta

Corryn Biotechnologies

The South-Wales-based company is an emerging player in the field of regenerative medicine, offering solutions for wound care management that maximise a patient's natural healing response and so help decrease the closing time of chronic and complex wounds.

Corryn Biotechnologies has raised €661k across 1 funding round from 1 investor, most recently a Seed round in Sep 2024. Based in South Wales, UK; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€661k
€660,899
Funding rounds
1
Investors
1
distinct backers
Active since
2024-09
latest 2024-09

Funding by year

EUR raised per year
Corryn Biotechnologies — funding by year — interactive chart.
Data table
Corryn Biotechnologies — funding by year
2024€661k

Signals

High confidence
Raise-next likelihood23
base rate 44% for Seed
  • ▼ Past typical raise window
  • ▼ Low backer re-investment

Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

1 round
DateStageAmountInvestors
2024-09-24Seed€661kBritish Design FundView deal →

Related news

Similar companies

same sector or country
  • Nscale
    UK · Cloud
    €11B
  • Arm
    UK · Semiconductors
    €4.7B
  • DAZN
    UK · Software
    €3.8B
  • SumUp
    UK · Fintech
    €3.5B
  • CityFibre
    UK · Telecom
    €3.0B
  • Philips
    Netherlands · Healthtech
    €2.6B

Global coverage: FundingData